O1-conotoxin Tx6.7 cloned from the genomic DNA of

Conus textile Tx6.7 calcium currents conotoxin hCaV1.2 hCaV2.2

Journal

The journal of venomous animals and toxins including tropical diseases
ISSN: 1678-9199
Titre abrégé: J Venom Anim Toxins Incl Trop Dis
Pays: Brazil
ID NLM: 101201501

Informations de publication

Date de publication:
2023
Historique:
received: 08 12 2022
accepted: 13 04 2023
medline: 7 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: epublish

Résumé

Conotoxins exhibit great potential as neuropharmacology tools and therapeutic candidates due to their high affinity and specificity for ion channels, neurotransmitter receptors or transporters. The traditional methods to discover new conotoxins are peptide purification from the crude venom or gene amplification from the venom duct. In this study, a novel O1 superfamily conotoxin Tx6.7 was directly cloned from the genomic DNA of Patch clamp experiments on rat DRG neurons showed that Tx6.7 inhibited peak calcium currents by 59.29 ± 2.34% and peak potassium currents by 22.33 ± 7.81%. In addition, patch clamp on the ion channel subtypes showed that 10 μM Tx6.7 inhibited 56.61 ± 3.20% of the hCa Our results suggested that direct cloning of conotoxin sequences from the genomic DNA of cone snails would be an alternative approach to obtaining novel conotoxins. Tx6.7 could be used as a probe tool for ion channel research or a therapeutic candidate for novel drug development.

Sections du résumé

Background UNASSIGNED
Conotoxins exhibit great potential as neuropharmacology tools and therapeutic candidates due to their high affinity and specificity for ion channels, neurotransmitter receptors or transporters. The traditional methods to discover new conotoxins are peptide purification from the crude venom or gene amplification from the venom duct.
Methods UNASSIGNED
In this study, a novel O1 superfamily conotoxin Tx6.7 was directly cloned from the genomic DNA of
Results UNASSIGNED
Patch clamp experiments on rat DRG neurons showed that Tx6.7 inhibited peak calcium currents by 59.29 ± 2.34% and peak potassium currents by 22.33 ± 7.81%. In addition, patch clamp on the ion channel subtypes showed that 10 μM Tx6.7 inhibited 56.61 ± 3.20% of the hCa
Conclusion UNASSIGNED
Our results suggested that direct cloning of conotoxin sequences from the genomic DNA of cone snails would be an alternative approach to obtaining novel conotoxins. Tx6.7 could be used as a probe tool for ion channel research or a therapeutic candidate for novel drug development.

Identifiants

pubmed: 37283723
doi: 10.1590/1678-9199-JVATITD-2022-0085
pmc: PMC10241523
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e20220085

Déclaration de conflit d'intérêts

Competing interests : The authors declare that they have no competing interests.

Références

J Biol Chem. 1995 Jul 14;270(28):16796-802
pubmed: 7622492
Toxins (Basel). 2017 Dec 07;9(12):
pubmed: 29215605
Mar Drugs. 2019 Jun 21;17(6):
pubmed: 31234371
Mar Drugs. 2017 Oct 13;15(10):
pubmed: 29027927
Nucleic Acids Res. 2012 Jan;40(Database issue):D325-30
pubmed: 22058133
J Venom Anim Toxins Incl Trop Dis. 2020 May 08;26:e20190095
pubmed: 32425993
Toxicon. 2020 Sep;184:109-115
pubmed: 32540219
Toxicon. 2007 Jun 15;49(8):1135-49
pubmed: 17400270
Mar Drugs. 2021 Feb 11;19(2):
pubmed: 33670311
Ann N Y Acad Sci. 1999 May 18;870:223-37
pubmed: 10415486
Toxins (Basel). 2019 Feb 20;11(2):
pubmed: 30791616
J Biol Chem. 2000 Nov 10;275(45):35335-44
pubmed: 10938268
J Venom Anim Toxins Incl Trop Dis. 2021 Jun 11;27:e20200164
pubmed: 34234819
J Physiol. 2016 Oct 1;594(19):5369-90
pubmed: 27273705
Sci Rep. 2018 Jan 10;8(1):330
pubmed: 29321522
J Venom Anim Toxins Incl Trop Dis. 2023 Jan 27;29:e20220052
pubmed: 36756364
Toxicon. 2020 Oct 30;186:29-34
pubmed: 32758497
Transl Res. 2021 Aug;234:20-30
pubmed: 33422652
Toxicon. 2010 Jul;55(8):1491-509
pubmed: 20211197
Toxicon. 2017 May;130:11-18
pubmed: 28219625
PLoS One. 2013 Dec 13;8(12):e82495
pubmed: 24349297
Mol Biosyst. 2017 Nov 21;13(12):2453-2465
pubmed: 29090697
Br J Pharmacol. 2012 Aug;166(7):2148-60
pubmed: 22452751
Chem Rev. 2019 Nov 13;119(21):11510-11549
pubmed: 31633928
Curr Mol Pharmacol. 2015;8(2):110-22
pubmed: 25966690

Auteurs

Maojun Zhou (M)

Department of Oncology, NHC Key Laboratory of Cancer Proteomics, State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Manyi Yang (M)

Department of Hepatobiliary and Pancreatic Surgery, NHC Key Laboratory of Nanobiological Technology, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Huiling Wen (H)

School of Pharmacy, Gannan Medical University, Ganzhou, Jiangxi, China.

Shun Xu (S)

Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, China.

Cuifang Han (C)

Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, China.

Yun Wu (Y)

Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, China.

Classifications MeSH